OraSure Technologies
OSUR
About: OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Employees: 501
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
0.73% less ownership
Funds ownership: 87.86% [Q1] → 87.13% (-0.73%) [Q2]
9% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 54
12% less capital invested
Capital invested by funds: $221M [Q1] → $196M (-$26M) [Q2]
14% less funds holding
Funds holding: 180 [Q1] → 154 (-26) [Q2]
64% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 39
75% less call options, than puts
Call options by funds: $1K | Put options by funds: $4K
Financial journalist opinion
